Manipal Health Enterprises IPO
Healthcare • ₹9275cr
Medium risk because:
- 5 material risk factors disclosed in DRHP
- Heavy dependence on government or PSU customers
- High dependence on insurance and third-party administrators for revenue.
IPOFins risk score from DRHP risk factors, subscription demand & issue structure
Price Band
₹29-31
Lot Size
25 shares
Issue Size
₹9275cr
Open
29 Jul 2026
Close
31 Jul 2026
Subscription
4.90×
GMP +₹7 → est. ₹38
IPO Schedule
| Issue Open Date | 29 Jul 2026 |
| Issue Close Date | 31 Jul 2026 |
| Allotment Date | 03 Aug 2026 |
| Listing Date | 05 Aug 2026 |
About Manipal Health Enterprises
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care. Read more Discuss on Trading Q&A
Company Details
Founders / Promoters
Mr Dilip Jose
Founded
2010
Registrar
KARVY
Documents
DRHP / RHP Document (PDF)
View official prospectus →
Investment Analysis
Manipal Health Enterprises — IPOFins Verdict
QuantitativeDriven by QIB demand at 8.3x and moderate disclosed risk (6/10), Manipal Health Enterprises listed at a premium of 2003.2% to its issue price. The signals lean constructive — still confirm valuation against listed peers and read the DRHP before applying beyond one lot.
- A large network of multi-speciality hospitals supported by a wide base of doctors.
- Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
- Strong presence across key regions with ongoing expansion plans.
- Significant share of revenue from insurance and institutional payors.
- Established track record of growth in patient volumes and operations.
Score breakdown — what drove this verdict
Moderate risk from DRHP → score -0.4
Institutional subscription → score +1.0
Actual listing outcome → score +1.5
Base score: 5.0 · Final score = base + all factor adjustments, capped 1–10. Full methodology →
IPOFins Score is a quantitative signal from subscription demand, disclosed risk, and listing data — not investment advice. Not SEBI-registered.
Listing Performance
Issue Price
₹31
Listing Price
₹652
Listing Gain/Loss
+2003.23%
Listing Date
05 Aug 2026
Price Since Listing
Returns are measured against the ₹31 issue price.
Listing
₹652
+2003.2%
Want to buy this stock?
Trade Manipal Health Enterprises on the secondary market
FAQ
What is the price band of Manipal Health Enterprises IPO?
The price band is ₹29-31 per share with a lot size of 25 shares. Minimum investment: ₹775.
What does Manipal Health Enterprises do?
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care. Read more Discuss on Trading Q&A
Should I apply for Manipal Health Enterprises IPO?
Manipal Health Enterprises listed at ₹652 (+2003.2% premium to the ₹31 issue price) after 4.9x subscription. IPOFins Score 7/10: Driven by QIB demand at 8.3x and moderate disclosed risk (6/10), Manipal Health Enterprises listed at a premium of 2003.2% to its issue price. The signals lean constructive — still confirm valuation against listed peers and read the DRHP before applying beyond one lot.
Who founded Manipal Health Enterprises?
Manipal Health Enterprises was founded by Mr Dilip Jose in 2010.